Unaudited Finacial Results along with Limited Review Report for the quarter ended 30.06.2026

To Date: 04.08.2026 BSE Limited P.J. Towers, Dalal Street, Mumbai-400 001 Dear Sir/Madam, Sub: Outcome of Board Meeting held on 04.08.2026 Ref: Company’s Letter dated 30.07.2026 Unit: Gayatri BioOrganics Limited (Scrip Code: 524564) With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of Gayatri BioOrgaincs Limited held on Tuesday, 04.08.2026 at 02:30 p.m. at the Registered Office of the Company at B3, 3rd Floor, 6-3-1090, TSR Towers Raj Bhavan Road, Somajiguda, Hyderabad - 500082, Telangana the following were considered and approved/noted: 1. Un-Audited financial results for the quarter ended 30.06.2026. (Enclosed) 2. Limited Review Report for the quarter ended 30.06.2026. (Enclosed) 3. Change in name of Company from Gayatri BioOrganics Limited to Ananth BioOrganics Limited / Ananth International BioOrganics Limited/ Ananth Global BioOrganics Limited/Anantha BioOrganics Limited/ Anantha International BioOrganics Limited/Anantha Global BioOrganics Limited or such other name as may be approved, subject to reservation and approval of the name from Central Registration Centre, Manesar (Delhi) and further subject to approval of the members and all other applicable statutory and regulatory approvals. 4. Resignation of Mr. Venkata Sandeep Kumar Reddy Tikkavarapu (DIN: 00005573), as Chairman and Non-Executive Director of the Company w.e.f. 05.08.2026, due to his professional responsibilities and personal reasons. He has confirmed that there are no other material reasons for his resignation other than that mentioned in his resignation letter. 5. Change in designation of Mr. Sreedhara Reddy Kanaparthi (DIN: 09608890) from Whole- time Director to Chairman and Managing Director of the Company, with effect from 05.08.2026 for a period of three years, subject to the approval of the members. (Brief profile is enclosed) 6. 35th Directors Report for the Financial year 2025-26 and notice for convening 35th Annual General Meeting (AGM) for the Financial Year 2025-26. 7. 35th Annual General meeting for the FY 2025-26 is scheduled to be held on Wednesday, 23rd September 2026 at 11:00 a.m. through video Conference or Other Audio-visual means (OAVM). 8. Approved the adoption of a new set of the Memorandum of Association (“MOA”) and Articles of Association (“AOA”) of the Company in substitution of the existing MOA and AOA, to align with the provisions of the Companies Act, 2013, subject to the approval of the Members of the Company. Disclosure of information with regard to item no 4 and 5 as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para-A of Schedule-III are provided below as Annexure-A. The meeting concluded at 05:50 p.m. Thanking you. Yours sincerely, For Gayatri BioOrganics Limited Sreedhara Reddy Kanaparthi Whole-Time Director DIN: 09608890 Annexure-A Details as required under Part A of Schedule III and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No: SEBI/HO/CFD/PoD2/CIR/P/0155 dated January 30, 2026 is provided below: S. No Particulars Mr. Sreedhara Reddy Mr. Venkata Sandeep Kumar Kanaparthi Reddy Tikkavarapu 1. Reason for Change viz. Change in designation of Mr. Venkata Sandeep Kumar appointment, reappointment, Mr. Sreedhara Reddy Reddy Tikkavarapu has resignation, removal, death or Kanaparthi (DIN: resigned from the position of otherwise 09608890) from Whole- Non-Executive Director of time Director to Chairman the company due to his and Managing Director. professional responsibilities and personal reasons. 2. Date of Appointment / 05.08.2026 Resigned w.e.f 05.08.2026 Cessation 3. Terms of appointment Period of 3 years Not applicable 4. Brief profile (in case of Mr. Sreedhara Kanaparthi Not applicable appointment) Reddy is a dynamic leader with a global network in the USA, India, China, the Middle East, and Europe. He has management experience in handling mid-sized and large companies in India and abroad after pursuing his Master of Business Administration during 1999–2001. The past 20 years of using technology to improve human lives have been the epitome of creativity and education. 5. Disclosure of Relationships No Relationship with Not applicable with other Directors (in case other Directors of appointment) 6. Shareholding, if any in the Not applicable 1,70,06,802 company 7. Affirmation that the Director To the best of our Not applicable being appointed is not knowledge and debarred from holding the information, we hereby office of director by virtue of affirm that Mr. Sreedhara any SEBI order or any other Reddy Kanaparthi is not such authority debarred from holding the office of Director by virtue of any SEBI order or any other such authority. 8. Name of listed entities in Not applicable Not applicable which the resigning Director holds directorship GAYATRI GAYATRI BIOORGANICS LIMITED Registered office: B3, Third floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad - 500 082 Website: www.gayatribioorganics.com, CIN: L24110TG1991PLC013512 STATEMENT OF UNAUDITED FINANCIALS RESULTS FOR THE QUARTER JUNE 30, 2026 (X in Lakhs unless otherwise stated) Quarter Ended Year ended sr. Particulars June 30,2026 | March 31,2026 | June 30,2025 | March 31, 2026 Unaudited Audited Unaudited Audited 1/Income Revenue from Operations 233.66 2 Other Income - - - - Total Income 233.66 E - - 2 |Expenses L Purchase of Stock-In-Trade 21545 - Changes in Inventories of Finished Goods and Work in Progress = - - - Employee Benefits Expenses 211 222 5.02 11.29 Finance Cost 10.68 9.74 8.04 35.77 Depreciation and Amortisation Expenses E = - - Other Expenses 15.60 30.09 13.23 64.12 Total Expenses 243.84 4205 2629 L8 3 |Profit/(Loss) before exceptional and extraordinary items and tax (1-2) 10.17) (42.05) (26.29) (111.18), 4 |Add/(Less): Exceptional ltems - - - - 5 [Profit/ (loss) before tax for the period / year (3-4) (10.17) (42.05), (26.29) (111.18)] 6 |Tax Expense = » - 7 [Net Profit/(Loss) after tax (5-6) (10.17) (42.05) (26.29) (111.18) 8 |Other Comprehensive Income (net of Tax) Items that will not be reclassified to Statement of Profit and Loss (a) Remeasurement of employee benefit obligation 5 = - - (b) Income tax relating to above item - - - - 9 |Total Comprehensive Income/(Loss) for the period / year (After tax) (7+8) (10.17) (42.05) (26.29) (111.18)) 10 [Paid-up Equity Share Capital 7878 81 7,878.81 7.878.81 787881 11 |Other Equity (11,579.31) (3,700.49) 12 [Networth 13 [Earnings per share in ¥ (annualised except for quarter) Basic 0.01) 0.05) (0.03) (0.14)| Diluted (0.01)] (0.05)] (0.03) (0.14)] (see accompanying notes (o the financial results) Regd. & Corp. Office Gayatri Bio (rganics Limited, B3, 3rd Floor, 6-3-1090, TSR Towers T +914066100111/6610 0222 E info@gayatribioorganics.com Raj Bhavan Road, Somajiguda, Hyderabad 500 082. Telangana F 4914066100333 gayatribioorganics @gmail.com www.gayatribiocrganics.com CIN NO : L24110AP1991PLC013512 GAYATRI NOTES The above financial results were reviewed by the Audit Committee and taken on record by the Board of Dircetors at thei respective meeting held on 4th August, 2026 aT sh e p ra eb sco rv ie b ef di n ua nn dci ea rl sr ee cs tu il ot ns a 1r 3e 3 e ox ft r ta hc et Ced o mf pr ao nm i eth se AA cu td ,i 2t 0ed 1 3F i (n "a thn ec i Aa cl t "S )t a rt ee am de wn it ts h o rf e t lh ee v aC no t m rp ua len sy i, s sw uh ei dc th h ea rr ce u p nr de ep ra red in accordance with Indian Accounting Standards (Ind AS") The financial statements have been prepared on a going concern basis based pon Comfortleer given by the promoters o the Company for any other business o be continucd by them in the future. The Company doesn't have more than one segment Therefore, disclosure relating to segments i not applicable and accordingly mot made. 5 e figures forthe correspanding, previous period have been regrouped reclassified/restated [Showing first 8,000 characters — download PDF for full document]